As shown in Figure 2B, analysis of the same panel of NSCLC cell lines that were assessed in Figure 1C, indicated there to be no significant difference in CDCA3 transcript expression between EGFR wild-type and mutant cell lines. This evidence concerns the gene EGFR and non-small cell lung carcinoma.